Metraipolis › archive › dc_d656d725f84f

Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU — Europe PMC PMID:28520731

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/28520731
DOI: 10.1371/journal.pone.0176286
License (as archived): solo-consultazione
Archived: 2026-10-07T17:58:03.410Z
SHA-256 of the archived text: 5046f450afe27b1407870761b00f298e0b078879ca0d240d2e2da657ce431120
Stable URL of this page: https://metraipolis.com/documento/dc_d656d725f84f

How to cite

Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU — Europe PMC PMID:28520731 — Europe PMC (en), https://europepmc.org/article/MED/28520731 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d656d725f84f (Metraipolis archive dc_d656d725f84f, sha256 5046f450afe27b1407870761b00f298e0b078879ca0d240d2e2da657ce431120)

BibTeX

@misc{dcd656d725f84f,
  title = {Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU — Europe PMC PMID:28520731},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/28520731},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d656d725f84f; sha256 5046f450afe27b1407870761b00f298e0b078879ca0d240d2e2da657ce431120},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28520731. Agents can read the archived copy with the MCP tool read_document.